FNR is an Escherichia coli transcription factor that regulates the transcription of many genes in response to anaerobiosis. We have constructed a series of artificial FNR-dependent promoters, based on the melR promoter, in which a consensus FNR binding site was centered at position ؊41.5 relative to the transcription start site. A second consensus FNR binding site was introduced at different upstream locations, and promoter activity was assayed in vivo. FNR can activate transcription from these promoters when the upstream FNR binding site is located at many different positions. However, sharp repression is observed when the upstreambound FNR is located near positions ؊85 or ؊95. This repression is relieved by the FNR G74C substitution mutant, previously identified as being defective in transcription repression at the yfiD promoter. A parallel series of artificial FNR-dependent promoters, carrying a consensus FNR binding site at position ؊61.5 and a second upstream DNA site for FNR, was also constructed. Again, promoter activity was repressed by FNR when the upstream-bound FNR was located at particular positions.
The regulator of fumarate and nitrate reduction (FNR) and the cyclic AMP receptor protein (CRP) are related transcription activators which control the expression of networks of Escherichia coli genes in response to oxygen starvation and glucose starvation, respectively. Both FNR and CRP bind as dimers to specific 22-bp sequences located at target promoters, and the specificity of DNA recognition and the mechanisms by which FNR and CRP activate transcription have been extensively studied (reviewed in references 8 and 13). Both FNR and CRP can activate transcription by recruiting holo RNA polymerase (RNAP) to target promoters via direct interactions with the C-terminal domain of the RNAP ␣ subunit (␣CTD) (reviewed in reference 7). Many target promoters contain just one DNA site for FNR or CRP, and they can be grouped into two classes according to the location of this site. At Class I promoters the activator binds to a site located upstream from the promoter Ϫ35 element and makes direct contact with one ␣CTD, which binds immediately downstream of the bound FNR or CRP dimer. At Class II promoters the activator binds to a site that overlaps the Ϫ35 element and makes direct contact with the ␣CTD that binds immediately upstream of the bound FNR or CRP. Interestingly, although RNAP contains two ␣ subunits and hence two ␣CTDs, activation at these promoters requires contact with only one ␣CTD (18) .
Many FNR-and CRP-regulated promoters contain two DNA sites for FNR or CRP (8, 13) . At some of the CRPregulated promoters, optimal expression depends on the binding of CRP to both target sites. To account for this, Busby and Ebright (7) proposed that each bound CRP contacts one of the two ␣CTDs. Systematic studies of promoters carrying tandem DNA sites for CRP were performed by Belyaeva et al. (3) and Tebbutt et al. (24) . Belyaeva et al. (3) started with a Class II CRP-dependent promoter carrying a single DNA site for CRP (centered at position Ϫ41.5) and introduced a second site at different upstream locations. Activation by the tandem-bound CRP was increased when the upstream-bound CRP was located at certain positions. Similarly, Tebbutt et al. (24) studied a Class I promoter carrying a single DNA site for CRP (centered at position Ϫ61.5) and observed increased activation when a second DNA site for CRP was located at certain upstream positions.
The many similarities between FNR and CRP suggest that tandem-bound FNR molecules should also be able to cooperate at a target promoter to activate transcription synergistically. However, present evidence suggests that this is not the case. For example, the E. coli yfiD promoter is activated by FNR binding to a target site centered at position Ϫ40.5, but this activation is suppressed rather than enhanced by FNR binding to an additional upstream site, located at position Ϫ93.5 (12) . Green and collaborators have presented evidence that this down-regulation results from specific interactions between the two tandem-bound FNR molecules and that these interactions are dependent on the spacing between the bound FNR molecules (11, 20) . The main purpose of this study was to make a systematic investigation of promoters with tandem DNA sites for FNR. One aim was to search for promoter architectures where tandem-bound FNR molecules would cooperate to activate transcription. Thus, starting with the Class II CRP-dependent promoters described by Belyaeva et al. (3) that carry a second DNA site for CRP at different upstream locations, we generated a related set of promoters with two DNA sites for FNR. Studies with these promoters show that upstream-bound FNR suppresses rather than enhances transcription. Similarly, starting with the Class I CRP-dependent promoters described by Tebbutt et al. (24) , which carry a second upstream DNA site for CRP, we generated a second set of promoters with two DNA sites for FNR. Studies with these promoters show that upstream-bound FNR can either suppress or enhance transcription according to its location.
MATERIALS AND METHODS
Strains, plasmids, and materials. The bacterial strains and plasmids used in this study are listed in Table 1 . Cultures of E. coli were grown in Luria Bertani medium (LB) (20 g of tryptone, 10 g of NaCl, 10 g of yeast extract per liter) supplemented with appropriate antibiotics (ampicillin, 100 g ml Ϫ1 ; tetracycline, 35 g ml Ϫ1 ). For agar plates, 16 g of agar per liter was added or MacConkey Agar (Difco) was used. DNA was isolated and manipulated by using standard methods. All of the new promoter constructs were checked by using the automated DNA sequencing facility at the Birmingham Functional Genomics Laboratory. Synthetic oligonucleotides for PCR and DNA sequencing were purchased from Alta Bioscience, University of Birmingham, or from Sigma.
Promoter constructions. All the promoters used in this study were cloned on EcoRI-HindIII fragments and were shuttled between pAA121 (for construction), pRW50 (for assay), and pSR (for in vitro studies). The starting point was the CC(Ϫ41.5) promoter and the series of derivatives described by Belyaeva et al. (3) carrying a second upstream DNA site for CRP. CC(Ϫ41.5) is a derivative of the E. coli melR promoter carrying a consensus DNA site for CRP centered at position Ϫ41.5; expression is completely dependent on CRP. In the first set of experiments, the DNA sites for CRP in these promoters were changed to DNA sites for FNR to give FF(Ϫ41.5) and a series of promoter derivatives carrying tandem DNA sites for FNR (Fig. 1a) . To do this, oligo-directed mutagenesis was used to change the two TGTGA motifs in each 22-bp DNA site for CRP to TTTGA to create 22-bp DNA sites for FNR. These base changes are sufficient to switch binding specificity from CRP to FNR (2) .
Oligos used in the constructions are listed in Table 2 , and the PCRs used to make the different promoters are described in Table 3 . The FF(Ϫ41.5) promoter (Fig. 1a) was created from CC(Ϫ41.5) by PCR with primer AB1 (which covers the upstream EcoRI site and converts the DNA site for CRP into a site for FNR) and primer D2591 (which covers the downstream HindIII site). The PCR product was digested with EcoRI and HindIII, and the FF(Ϫ41.5) EcoRI-HindIII fragment was cloned into pAA121.
The Belyaeva et al. (3) . To do this, first the upstream DNA site for CRP was changed to a site for FNR by PCR, using primers AB1 and D2591 as described above. The PCR products were digested with EcoRI and HindIII, and the resulting fragments were cloned into pAA121. These FF(Ϫn)CC(Ϫ41.5) constructs were then used as templates in a second PCR amplification using primers AB4 (which anneals to pAA121 vector sequence just upstream of the EcoRI site) and AB5 (which changes the downstream DNA site for CRP to a site for FNR and introduces a BglII restriction site immediately downstream of the new FNR binding site). The resulting fragments were digested with EcoRI and BglII and were ligated to the EcoRI-BamHI vector fragment from pAA121 carrying the FF(Ϫ41.5) promoter. This created a set of pAA121 derivatives carrying different promoters with tandem DNA sites for FNR and a BglII-BamHI hybrid sequence located immediately downstream of the FF site at position Ϫ41.5 (Fig. 1a) .
Additional promoters were made from pAA121 derivatives carrying the FF (Ϫ90.5)FF(Ϫ41. 5) 5) , respectively, by PCR using primers AB2 and D2591. The products were digested with EcoRI and HindIII and were cloned into pAA121. The EE sequence is a derivative of the consensus DNA site for FNR, to which FNR is unable to bind (each TTTGA motif is replaced by TTTCA).
In a second series of constructions, the starting point was the CC(Ϫ61.5) promoter and the derivatives described by Tebbutt et al. (24) carrying a second upstream DNA site for CRP. CC(Ϫ61.5) is a derivative of the E. coli melR promoter carrying a consensus DNA site for CRP centered at position Ϫ61.5. The DNA sites for CRP in these promoters were changed to DNA sites for FNR to give FF(Ϫ61.5) and a series of promoter derivatives carrying tandem DNA sites for FNR (Fig. 1b) . Oligos used in the constructions are listed in Table 2 , and the PCRs used to make the different promoters are described in Table 3 . The FF (Ϫ61.5) promoter (Fig. 1b) was created from CC(Ϫ61.5) by PCR using primer AB1 and primer D2591. The PCR product was digested with EcoRI and HindIII, and the FF(Ϫ61.5) EcoRI-HindIII fragment was cloned into pAA121.
The different FF(Ϫn)FF(Ϫ61.5) promoters were derived from the corresponding CC(Ϫn)CC(Ϫ61.5) promoters described by Tebbutt et al. (24) . To do this, first the upstream DNA site for CRP was changed to a site for FNR by PCR using primers AB1 and D2591 as described above. The PCR products were digested with EcoRI and HindIII, and the resulting fragments were cloned into pAA121. These FF(Ϫn)CC(61.5) constructs were then used as templates in a second PCR amplification using primers AB4 and AB6 (which changes the downstream DNA site for CRP to a site for FNR and introduces a BglII restriction site immediately downstream of the new FNR binding site). The resulting fragments were digested with EcoRI and BglII and were ligated to the EcoRIBamHI vector fragment from pAA121 carrying the FF(Ϫ61.5) promoter. This created a set of pAA121 derivatives carrying different promoters with tandem DNA sites for FNR with the downstream site at position Ϫ61.5 (Fig. 1b) .
Assay of promoter activity in vivo. To measure promoter activities in vivo, promoters were cloned into the lac expression vector, pRW50, as previously described (19) , and the constructs were used to transform ⌬lac E. coli strains. ␤-Galactosidase activities of the transformants were assayed according to Miller (22) as follows: 10-ml cultures were grown overnight in 25-ml conical flasks in a shaking water bath at 37°C. The growth medium was LB supplemented with 0.2% fructose and appropriate antibiotics. The following morning 100 l of the overnight cultures was used to inoculate 10 ml of fresh medium contained in narrow capped tubes. The cultures were grown anaerobically, without shaking, at 37°C for 4 to 5 h to an optical density at 650 nm of 0.3 to 0.4 and was lysed with a mixture of toluene and 1% sodium deoxycholate prior to the assay. ␤-Galactosidase activities are reported relative to the activity obtained using the FF (Ϫ41.5) or FF(Ϫ61.5) promoters (approximately 10,000 and 500 Miller units, respectively). Each activity is the average of at least three independent determinations. Error bars represent one standard deviation from the mean. Purification of FNR D154A. The aerobically active FNR* derivative, FNR D154A (16), was purified as a C-terminally His-tagged fusion protein by using a method adapted from that described by Wing et al. (26) for use with the Ä KTAprime protein purification system (Amersham Biosciences). E. coli XL1-Blue cells were transformed with a pQE60 derivative encoding the C-terminally His-tagged FNR D154A fusion protein. Transformants were grown at 37°C in 100 ml of LB supplemented with 100 g of ampicillin ml
Ϫ1 to an optical density at 650 nm of 0.4. Overexpression of the His-tagged protein was then induced by the addition of 0.1 M isopropyl-1-thio-D-galactopyranoside (IPTG) for 1 h. Cells were harvested, and pellets were sonicated in 10 ml of lysis buffer at 4°C (1 mg of lysozyme ml Ϫ1 , 50 mM NaH 2 PO 4 -Na 2 HPO 4 [pH 8.0], 0.75 M NaNO 3 , 10 mM imidazole, 10 mM benzamidine). Sonicates were centrifuged at 10,000 ϫ g and were passed through a 0.2-m-pore-size filter before being applied to a 1-ml HiTrap Chelating HP column (Amersham Biosciences), which had been equilibrated with 1 M NiSO 4 followed by FNR wash buffer (50 mM NaH 2 PO 4 -Na 2 HPO 4 [pH 8.0], 0.75 M NaNO 3 ). His-tagged FNR D154A was eluted from the column by applying FNR elution buffer with a gradient of imidazole (50 mM NaH 2 PO 4 -Na 2 HPO 4 [pH 8.0], 0.75 M NaNO 3 , to 250 mM imidazole over 30 min). The purity of the protein fractions was estimated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Fractions containing His-tagged FNR D154A were pooled and concentrated by using a Vivaspin 50,000-molecularweight cutoff concentrator (Vivascience) before the addition of glycerol to a final concentration of 50% (vol/vol). Protein concentration was estimated by the Bradford method (4).
In vitro transcription assays. Derivatives of pSR carrying different FNRregulated promoters cloned upstream of the lambda oop transcription terminator were used as templates for in vitro transcription. Plasmid DNA (8 nM Samples were run in 1ϫ Tris-borate-EDTA (TBE) on a 5.5% denaturing polyacrylamide gel at 12 V cm Ϫ1 and were analyzed by using a phosphorimager and Bio-Rad Quantity One software. FNR-dependent transcripts were quantified with reference to the FNR-independent RNA1 transcript, encoded by the pSR vector.
DNaseI footprint analysis. DNaseI footprinting was performed essentially as described by Savery et al. (23) . The reaction mixtures contained AatII-HindIII promoter fragments that had been labeled at the HindIII site with [␥-32 P]ATP and 0 to 3 M purified FNR D154A. The reaction buffer consisted of 20 mM HEPES (pH 8.0), 5 mM MgCl 2 , 50 mM potassium glutamate, 1 mM DTT, 0.5 mg of BSA ml Ϫ1 , and 0.1 mg of herring sperm DNA ml Ϫ1 . After treatment with DNaseI (approximately 0.5 ng l Ϫ1 for 30 to 60 s), the reactions were stopped by the addition of DNaseI Stop buffer (10 mM EDTA, 0.3 M sodium acetate). Footprinting reactions were resuspended in formamide buffer and were analyzed on 6% polyacrylamide sequencing gels calibrated with Maxam-Gilbert GϩA sequencing ladders and visualized by using a phosphorimager and Bio-Rad Quantity One software.
Electromobility shift assays. Purified EcoRI-HindIII promoter fragments were prepared from cesium chloride preparations of DNA. These fragments were end-labeled with [␥-32 P]ATP, and 0.5 to 2.5 ng of each fragment was incubated with 0 to 5.6 M concentrations of purified FNR D154A. The sample buffer contained 0.1 M potassium glutamate, 1 mM EDTA, 10 mM potassium phosphate buffer (pH 7.5), 50 M DTT, 5% glycerol, 0.5 g of BSA ml Ϫ1 , and 25 ng of herring sperm DNA (Gibco) ml Ϫ1 in a 10-l final reaction volume. Following incubation at 37°C for 20 min, samples were run in 0.25ϫ TBE on a 6% polyacrylamide gel at 12 V cm Ϫ1 and were analyzed by using a phosphorimager and Bio-Rad Quantity One software.
Permanganate footprint analysis. Reaction mixtures contained AatII-HindIII promoter fragments that had been labeled at the HindIII site with [␥-32 P]ATP, 0 to 1 M purified FNR D154A, and 0 to 50 nM RNAP. The reaction buffer consisted of 20 mM HEPES (pH 8.0), 5 mM MgCl 2 , 50 mM potassium gluta- mate, 1 mM DTT, and 0.5 mg of BSA ml Ϫ1 . After treatment with potassium permanganate (10 mM final concentration for 4 min) to modify single stranded T residues, reactions were quenched by the addition of 2.5 volumes of stop solution (3 M ammonium acetate, 0.1 mM EDTA, and 1.5 M ␤-mercaptoethanol). Following phenol-chloroform extraction, ethanol precipitation, and treatment with 1 M piperidine (90°C for 30 min), samples were resuspended in formamide buffer. Permanganate cleavage patterns were analyzed by using 6% polyacrylamide sequencing gels and were visualized with a phosphorimager and Bio-Rad Quantity One software.
RESULTS

Activity of promoters with tandem sites for FNR: the FF (؊n)FF(؊41.5) series.
We constructed a series of related promoters carrying one consensus DNA site for FNR centered at position Ϫ41.5 and a second consensus DNA site for FNR located further upstream [the FF(Ϫn)FF(Ϫ41.5) series] (Fig.  1a) . The starting point for these constructions was the CC(Ϫn)CC(Ϫ41.5) promoter series described in a previous study (Table 3) 
(3). Each new FF(Ϫn)FF(Ϫ41.5) promoter was
transferred into the low-copy lac expression vector pRW50. Measurements of ␤-galactosidase activities showed that expression from each promoter is anaerobically induced and is totally dependent on FNR (data not shown). Figure 2a illustrates the expression from each promoter in an fnr ϩ background during anaerobic growth. The results show that expression is dependent upon the spacing between the two DNA sites for FNR.
For comparison, Fig. 2b illustrates expression from the previously constructed promoters carrying tandem DNA sites for CRP [the CC(Ϫn)CC(Ϫ41.5) series] (3). As described before, in many cases the upstream DNA site for CRP hardly affects expression, but when located at certain positions, expression is increased two-to fourfold. Thus, when the upstream DNA site for CRP is located near positions Ϫ74.5, Ϫ84.5, Ϫ90.5, Ϫ93.5, and Ϫ101.5, the upstream-bound CRP activates transcription synergistically with the downstream-bound CRP at position Ϫ41.5. At intermediate locations, the upstream-bound CRP has little or no effect, and the observed expression is similar to that found at the CC(Ϫ41.5) promoter, with a single DNA site for CRP at position Ϫ41.5.
Comparison of data in Fig. 2a the FF(Ϫ41.5) promoter (with a single DNA site for FNR), suggesting little or no synergy between tandem-bound FNR molecules. Second, sharp repression of expression is found when the upstream FNR is located near position Ϫ85.5 or Ϫ95.5 (Fig. 2a) . Promoter activity is reduced to 10 to 20% of the activity of the FF(Ϫ41.5) promoter, and this reduction appears to depend on the helical juxtaposition of the tandembound FNR molecules.
As controls, we selected the FF(Ϫ85.5)FF(Ϫ41.5) and FF (Ϫ90.5)FF(Ϫ41.5) promoters and converted the upstream DNA sites for FNR to EE sequences, which are unable to bind either FNR or CRP. The resulting EE(Ϫ85.5)FF(Ϫ41.5) and EE(Ϫ90.5)FF(Ϫ41.5) promoters were transferred into pRW50, and their activities were measured. Results in Table 4 show that expression from these promoters is dependent on FNR. Expression from both the EE(Ϫ85.5)FF(Ϫ41.5) and EE (Ϫ90.5)FF(Ϫ41.5) promoters is similar to that observed with FF(Ϫ41.5). This argues that both the sharp decrease due to the upstream DNA site for FNR at the FF(Ϫ85.5)FF(Ϫ41.5) promoter and the small increase due to the upstream DNA site for FNR at the FF(Ϫ90.5)FF(Ϫ41.5) promoter are due to FNR binding rather than to an artifact of the promoter context.
Suppression of FNR-dependent transcription repression by FNR G74C. Green and colleagues reported that the E. coli yfiD
promoter is activated by FNR binding to a target site centered at position Ϫ40.5. They found that this activation is suppressed by FNR binding to a second upstream site at position Ϫ93.5, but that the suppression can be partially relieved by the G74C substitution in FNR (11, 12) . This change appears to interfere with the FNR determinant responsible for down-regulation by upstream-bound FNR. Thus, we tested whether the G74C substitution could also relieve the suppression of the activity of the FF(Ϫn)FF(Ϫ41.5) promoters due to upstream-bound FNR. To do this, we introduced pRW50 derivatives carrying selected FF(Ϫn)FF(Ϫ41.5) promoter constructs into the M182 fnrA1 strain containing a plasmid encoding either wild-type FNR (pFNR) or FNR G74C (pFNR G74C). Promoter activities were measured and are listed in Table 5 . Consistent with the results using the fnr ϩ M182 strain ( In vitro studies. To investigate tandem-bound FNR in vitro we focused on three promoters: the starting promoter, FF (Ϫ41.5), an FNR-repressed promoter, FF(Ϫ85.5)FF(Ϫ41.5), and FF(Ϫ90.5)FF(Ϫ41.5), which is not repressed by upstreambound FNR (Fig. 1a and 2a) . DNA fragments carrying the promoters were transferred to the vector pSR for these experiments. To facilitate in vitro studies we used the FNR* mutant, FNR D154A, which can dimerize, bind to DNA sites for FNR, and activate transcription by RNAP at FNR-dependent promoters in aerobic conditions (16, 17) .
First, we used DNaseI footprinting to monitor FNR binding to the different sites at the promoters. Clear footprints due to FNR D154A binding are observed (Fig. 3) . At the FF(Ϫ41.5) promoter, FNR D154A protects a single zone from positions Ϫ26 to Ϫ65 relative to the transcription start point, while at the FF(Ϫ85.5)FF(Ϫ41.5) and FF(Ϫ90.5)FF(Ϫ41.5) promoters FNR D154A protects two zones that correspond to the tandem binding sites. Parallel electromobility shift assays confirmed that FNR D154A can bind to two sites at the FF(Ϫ85.5)FF (Ϫ41.5) and FF(Ϫ90.5)FF(Ϫ41.5) promoters (data not shown).
Second, we used an in vitro transcription assay to measure FNR-dependent activation at the different promoters. Labeled RNA products from the assay were analyzed by using a phosphorimager, and the image is shown in Fig. 4a . Bands due to transcripts regulated by the different FNR-dependent promoters and due to the control RNA1 can be distinguished. With the FF(Ϫ41.5) and FF(Ϫ90.5)FF(Ϫ41.5) promoters, transcription is clearly activated by FNR. In contrast, no FNR-dependent transcript was found with the FF(Ϫ85.5)FF(Ϫ41.5) pro- b Cells were grown anaerobically in LB supplemented with 35 g of tetracycline ml Ϫ1 and 0.2% fructose, and ␤-galactosidase activity was determined as described in Materials and Methods. Activity is shown relative to the ␤-galactosidase activity obtained using the FF(Ϫ41.5) promoter in the M182 background and is the means of three independent determinations. The error is one standard deviation from the mean. a Promoters were cloned on EcoRI-HindIII fragments in the lac expression vector pRW50.
b ␤-Galactosidase activities were measured in M182 fnrA1 cells containing plasmids encoding either wild-type FNR (pFNR) or FNR G74C (pFNR G74C) and grown anaerobically in LB supplemented with 35 g of tetracycline ml Ϫ1 , 100 g of ampicillin ml Ϫ1 , and 0.2% fructose, as described in Materials and Methods. Activities are expressed relative to the activity obtained using the FF(Ϫ41.5) promoter in the M182 fnrA1 (pFNR) background (7, (Fig. 1b) . The starting point for these constructions was the CC(Ϫn)CC(Ϫ61.5) promoter series described in a previous study (Table 3 ) (24) . Each new FF(Ϫn)FF(Ϫ61.5) promoter was transferred into pRW50, and ␤-galactosidase activity measurements showed that expression is anaerobically induced and is dependent on FNR (data not shown). Figure 5a illustrates the expression from each promoter in an fnr ϩ background during anaerobic growth. The results show that expression depends on the spacing between the two DNA sites for FNR.
For comparison, Fig. 5b illustrates expression from the previously constructed promoters carrying tandem DNA sites for CRP [the CC(Ϫn)CC(Ϫ61.5) series] (24). As described before, when the upstream DNA site for CRP is located near position Ϫ93.5 or position Ϫ103.5, expression is increased up to five- fold. At intermediate locations the upstream-bound CRP has little or no effect, and the observed expression is similar to that found at the CC(Ϫ61.5) promoter, with a single DNA site for CRP at position Ϫ61.5.
Comparison of data in Fig. 5a and b shows both similarities and differences between the effects of upstream-bound FNR at the FF(Ϫn)FF(Ϫ61.5) promoters and the effects of upstreambound CRP at the CC(Ϫn)CC(Ϫ61.5) promoters. The upstream-bound FNR clearly causes increased expression when it is located near positions Ϫ92.5 and Ϫ102.5. At the intermediate positions, Ϫ94.5 and Ϫ99.5, the upstream-bound FNR has little or no effect, and the observed expression is similar to that found at the FF(Ϫ61.5) promoter, with a single DNA site for FNR at position Ϫ61.5. Thus, at these promoters the pattern of expression from the FF(Ϫn)FF(Ϫ61.5) and CC(Ϫn)CC (Ϫ61.5) series of promoters is at least superficially similar. However, with the FF(Ϫ104.5)FF(Ϫ61.5) and FF(Ϫ105.5)FF (Ϫ61.5) promoters, expression is sharply reduced by the upstream-bound FNR. Interestingly, at these promoters the center-to-center distances between the tandem DNA sites for FNR are 43 and 44 bp, which are identical to the distances between the DNA sites for FNR at the FF(Ϫn)FF(Ϫ41.5) promoters where greatest repression is observed (Fig. 2a) .
DISCUSSION
Tandem DNA sites for CRP or FNR are found at many promoters. At some of these, optimal expression depends on the binding of CRP to both target sites. In a study aimed to investigate this, Belyaeva et al. (3) started with the CC(Ϫ41.5) promoter (carrying a single DNA site for CRP) and introduced a second DNA site for CRP at different upstream locations. Belyaeva et al. (3) showed that the tandem-bound CRP molecule could activate transcription synergistically, provided it was located at particular positions. To explain their data, Belyaeva et al. (3) argued that synergy depended on the upstream and downstream CRP molecules being positioned such that they could each make productive interactions with ␣CTD of RNAP. When the upstream CRP was incorrectly positioned, it had no effect on CRP-dependent activation due to the CRP molecule at position Ϫ41.5 (although repression was found when the upstream-bound CRP was positioned at Ϫ71.5 or other downstream locations). In this study we performed a parallel experiment, starting with the FF(Ϫ41.5) promoter, which is dependent on FNR, and introducing a second DNA site for FNR at different upstream locations. Our results (Fig.  2) show that the pattern of expression from the FF(Ϫn)FF (Ϫ41.5) promoter series is very different from that observed by scription activation by FNR bound at position Ϫ41.5. Interestingly, the repression effect appears to be face-of-the-DNA helix-dependent, suggesting that it results from a particular juxtaposition of bound FNR molecules. Our in vitro studies show that, at least at the FF(Ϫ85.5)FF(Ϫ41.5) promoter, both FNR molecules bind but that transcription is hindered (Fig. 3  and 4a) . Interestingly, according to its reactivity with potassium permanganate, the target promoter can open (Fig. 4b) . However, kinetic studies will be needed to pinpoint the precise step that is down-regulated by upstream-bound FNR.
The overall conclusion from our study with the FF(Ϫn)FF (Ϫ41.5) series of promoters is that tandem-bound FNR molecules work together to repress rather than to activate transcription. This is consistent with conclusions from studies of the E. coli ndh and yfiD promoters, where repression is dependent on tandem binding of FNR. Expression from the ndh promoter is FNR independent but is repressed by FNR binding at positions Ϫ50.5 and Ϫ94.5 (21), with efficient repression requiring FNR binding to the more upstream site. Expression from the yfiD promoter is activated by FNR binding at position Ϫ40.5, but this activation is suppressed by the binding of upstream FNR at position Ϫ93.5 (12) . Strikingly, the center-tocenter distances between the tandem FNR sites at the ndh and yfiD promoters are 44 and 53 bp, respectively, which correspond to spacings that give sharp repression in the FF(Ϫn)FF (Ϫ41.5) promoter series. Working with the yfiD promoter, Green and colleagues (11, 20) have shown that down-regulation is due to specific interactions between the tandem-bound FNR molecules, which interact via a surface-exposed determinant. They have identified residues where substitutions prevent or reduce these interactions. We have studied the effects of one such substitution (G74C), and we found that it relieved, at least partially, the repression at the FF(Ϫn)FF(Ϫ41.5) promoters (Table 5 ).
In the final part of our study we performed a parallel set of constructions to make the FF(Ϫn)FF(Ϫ61.5) promoter series. Our results (Fig. 5) show that the pattern of expression of this promoter series is somewhat similar to that observed by Tebbutt et al. (24) for the CC(Ϫn)CC(Ϫ61.5) series. At some locations, upstream-bound FNR leads to increased promoter expression, although we can make no conclusion about synergy, since the controls to check that the tandem-bound FNR molecules functioned via the same promoter were not done. The striking result concerns the FF(Ϫ104.5)FF(Ϫ61.5) and FF (Ϫ105.5)FF(Ϫ61.5) promoters where expression is sharply reduced by the upstream-bound FNR. At these promoters the center-to-center distances between the tandem DNA sites for FNR are 43 and 44 bp. Taken together with previous results, we can conclude that 43 or 44 bp is a critical spacing for transcription repression by tandem-bound FNR molecules.
Many transcription activators can function as repressors if they are misplaced. Thus, both CRP and FNR can function as simple repressors merely by blocking access of RNAP to a promoter (8, 13) . To do this, a single correctly placed FNR or CRP molecule is needed (10, 25) . However, as well as using this simple repression mechanism, FNR has evolved a second repression strategy that depends on interactions between tandem-bound FNR molecules. This study shows that these interactions can occur in different contexts and that they are optimal when the spacing between the two FNR molecules is around 44 or 53 bp. These interactions appear to depend solely on FNR, but we are still ignorant of their precise nature. While FNR and CRP appear to have evolved from a common ancestor, CRP seems to have evolved so that tandem-bound CRP molecules can function synergistically to activate transcription at target promoters. In contrast, FNR has evolved so that tandem-bound FNR molecules cooperate in repression (5) .
